Gracell Biotechnologies News

GRCLDelisted Stock  USD 4.02  0.26  6.07%   
About 61% of Gracell Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Gracell Biotechnologies suggests that many traders are alarmed regarding Gracell Biotechnologies' prospects. Gracell Biotechnologies' investing sentiment shows overall attitude of investors towards Gracell Biotechnologies.
  
over a year ago at news.google.com         
Private equity firms are Gracell Biotechnologies Inc.s biggest owners and were rewarded after market...
Google News at Macroaxis
over a year ago at simplywall.st         
Private equity firms are Gracell Biotechnologies Inc.s biggest owners and were rewarded after market...
Simply Wall St News at Macroaxis
over a year ago at thelincolnianonline.com         
Gracell Biotechnologies Receives New Coverage from Analysts at Stifel Nicolaus
news
over a year ago at seekingalpha.com         
Gracell stock gains as Stifel issues Buy
seekingalpha News
over a year ago at marketwatch.com         
Gracell Biotechnologies started at buy with 11 stock price target at Stifel
marketwatch News
over a year ago at news.google.com         
Nkarta charts a new course that includes autoimmune disease - BioWorld Online
Google News at Macroaxis
over a year ago at news.google.com         
Claudin 18.2-Targeted Immunotherapy Research Report 2023 ... - Business Wire
Google News at Macroaxis
over a year ago at news.google.com         
Gracell Biotechnologies Doses First Person in Phase 1b2 Trial in ... - Marketscreener.com
Google News at Macroaxis
over a year ago at globenewswire.com         
Gracell Biotechnologies Doses First Patient in Phase 1b2 Clinical Trial in U.S. Evaluating GC012F fo...
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
Investors turn to basic research as they face uncertainties in China - The Pharma Letter
Google News at Macroaxis
over a year ago at news.google.com         
Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis ... - GlobeNewswire
Google News at Macroaxis
over a year ago at news.google.com         
Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis ... - PR Newswire
Google News at Macroaxis
over a year ago at news.google.com         
Gracell Biotechnologies CEO Dr. William Cao Named to Prestigious PharmaVoice 100, Honoring Most Insp...
Google News at Macroaxis
over a year ago at globenewswire.com         
Gracell Biotechnologies CEO Dr. William Cao Named to Prestigious PharmaVoice 100, Honoring Most Insp...
Macroaxis News: globenewswire.com
over a year ago at finance.yahoo.com         
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences
Yahoo News
Far too much social signal, news, headlines, and media speculation about Gracell Biotechnologies that are available to investors today. That information is available publicly through Gracell media outlets and privately through word of mouth or via Gracell internal channels. However, regardless of the origin, that massive amount of Gracell data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Gracell Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Gracell Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Gracell Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Gracell Biotechnologies alpha.

Gracell Biotechnologies Performance against Dow Jones

 Price Growth (%)  
       Timeline  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Gracell Stock

If you are still planning to invest in Gracell Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gracell Biotechnologies' history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon